Vincristine Enhances the Efficacy of MEK Inhibitors in Preclinical Models of KRAS-mutant Colorectal Cancer.
Ghosh S, Fan F, Powell RT, Roszik J, Park YS, Stephan C, Sebastian M, Tan L, Sorokin AV, Lorenzi PL, Kopetz S, Ellis LM, Bhattacharya R.
Ghosh S, et al. Among authors: ellis lm.
Mol Cancer Ther. 2023 Aug 1;22(8):962-975. doi: 10.1158/1535-7163.MCT-23-0110.
Mol Cancer Ther. 2023.
PMID: 37310170